Search Orphan Drug Designations and Approvals
-
Generic Name: | Glucagon-like peptide-1/Glucagon/Gastric inhibitory polypeptide triple agonist linked to human IgG4 Fc fragment |
---|---|
Date Designated: | 03/09/2020 |
Orphan Designation: | Treatment of primary biliary cholangitis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Hanmi Pharmaceutical Company, Ltd. 14, Wiryeseong-daero Seoul, Songpa-gu South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-